feed,title,long_url,short_url
SeekingAlpha,Olaplex faces reputational challenge after Cavallari post,https://seekingalpha.com/news/3916877,
SeekingAlpha,Kymera surges 30% as Sanofi plans to advance drug after promising data in skin disorders,https://seekingalpha.com/news/3916875,
